AVITA Medical, Inc. (RCEL)
USD 7.35
(-2.2%)
USD 7.35
(-2.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2022 | 449.48 Thousand USD | 0.0% |
| 2020 | 1.91 Million USD | -30.99% |
| 2019 | 2.77 Million USD | 0.0% |
| 2017 | 134.24 Thousand USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 417.5 Thousand USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 75.35 Thousand USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | 2.87 Million USD | 82.58% |
| 2023 Q2 | 1.57 Million USD | -14.91% |
| 2023 Q1 | 1.84 Million USD | 310.99% |
| 2022 Q2 | 770.54 Thousand USD | -20.57% |
| 2022 Q3 | 633.21 Thousand USD | -17.82% |
| 2022 FY | 449.48 Thousand USD | 0.0% |
| 2022 Q4 | 449.48 Thousand USD | -29.02% |
| 2022 Q1 | 970.15 Thousand USD | 0.0% |
| 2021 Q3 | 1.1 Million USD | 26.08% |
| 2021 Q1 | 1.39 Million USD | -13.16% |
| 2021 Q2 | 878 Thousand USD | -37.08% |
| 2020 Q4 | 1.6 Million USD | -35.22% |
| 2020 FY | 1.91 Million USD | -30.99% |
| 2020 Q2 | 2.77 Million USD | 0.0% |
| 2020 Q3 | 2.48 Million USD | -10.69% |
| 2019 FY | 2.77 Million USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q4 | 3.12 Million USD | 0.0% |
| 2018 Q2 | 134.24 Thousand USD | 0.0% |
| 2018 Q4 | 83.03 Thousand USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 FY | 134.24 Thousand USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q4 | 138.87 Thousand USD | 0.0% |
| 2008 Q2 | 417.5 Thousand USD | 0.0% |
| 2008 FY | - USD | -100.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | 417.5 Thousand USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2002 Q4 | 75.35 Thousand USD | 0.0% |
| 2002 FY | 75.35 Thousand USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 98.755% |
| BrainsWay Ltd. | 239 Thousand USD | -88.068% |
| Cerus Corporation | 59.79 Million USD | 99.248% |
| Envoy Medical, Inc. | 404 Thousand USD | -11.258% |
| electroCore, Inc. | 537 Thousand USD | 16.297% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -3645.692% |
| IceCure Medical Ltd | 376 Thousand USD | -19.543% |
| Inogen, Inc. | 18.27 Million USD | 97.54% |
| OrthoPediatrics Corp. | 13.45 Million USD | 96.66% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -125.871% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -23.578% |
| MaxCyte, Inc. | 17.96 Million USD | 97.499% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -713.044% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.517% |
| PAVmed Inc | 2.96 Million USD | 84.815% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 92.767% |
| RxSight, Inc. | 1.21 Million USD | 62.883% |
| Sight Sciences, Inc. | 31.7 Million USD | 98.582% |
| SI-BONE, Inc. | 36.06 Million USD | 98.754% |
| TELA Bio, Inc. | 40.51 Million USD | 98.891% |
| Treace Medical Concepts, Inc. | 53 Million USD | 99.152% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 70.448% |
| Acutus Medical, Inc. | 32.65 Million USD | 98.623% |
| Talis Biomedical Corporation | 16.78 Million USD | 97.322% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 88.888% |
| CVRx, Inc. | 30.38 Million USD | 98.521% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | 55.8% |
| Bioventus Inc. | 366.99 Million USD | 99.878% |
| Venus Concept Inc. | 70.79 Million USD | 99.365% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 63.868% |
| LivaNova PLC | 568.54 Million USD | 99.921% |
| 908 Devices Inc. | 3.92 Million USD | 88.56% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.912% |
| Nemaura Medical Inc. | 3.08 Million USD | 85.443% |
| NeuroPace, Inc. | 56.95 Million USD | 99.211% |
| LENSAR, Inc. | 1.75 Million USD | 74.315% |
| Apyx Medical Corporation | 33.18 Million USD | 98.646% |
| Cutera, Inc. | 418.69 Million USD | 99.893% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 97.012% |
| BioSig Technologies, Inc. | 103 Thousand USD | -336.391% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 98.329% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 95.482% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.97% |
| Axonics, Inc. | 25.84 Million USD | 98.261% |
| Outset Medical, Inc. | 134.59 Million USD | 99.666% |
| IRIDEX Corporation | 1.75 Million USD | 74.33% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 99.124% |
| IRadimed Corporation | 1.61 Million USD | 72.17% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -155.388% |
| INVO Bioscience, Inc. | 6.77 Million USD | 93.367% |
| Telesis Bio, Inc. | 5.26 Million USD | 91.469% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 92.473% |
| Varex Imaging Corporation | 464.2 Million USD | 99.903% |
| Quipt Home Medical Corp. | 60.82 Million USD | 99.261% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 23.557% |
| Pulmonx Corporation | 35.08 Million USD | 98.719% |
| Dynatronics Corporation | 3.25 Million USD | 86.206% |
| Modular Medical, Inc. | 817 Thousand USD | 44.984% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -197.671% |
| Semler Scientific, Inc. | 70 Thousand USD | -542.119% |
| InMode Ltd. | 6.61 Million USD | 93.203% |
| Bruker Corporation | 1.14 Billion USD | 99.961% |
| Cytosorbents Corporation | 2.54 Million USD | 82.324% |
| DexCom, Inc. | 2.57 Billion USD | 99.983% |
| Align Technology, Inc. | 96.96 Million USD | 99.536% |
| Viveve Medical, Inc. | 5.12 Million USD | 91.228% |
| ZimVie Inc. | 508.79 Million USD | 99.912% |
| Movano Inc. | 15.00 USD | -2996453.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 97.52% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.887% |
| Profound Medical Corp. | 4.97 Million USD | 90.964% |
| Insulet Corporation | 1.36 Billion USD | 99.967% |
| enVVeno Medical Corporation | 1.06 Million USD | 57.755% |
| Surmodics, Inc. | 29.4 Million USD | 98.471% |
| iCAD, Inc. | 273 Thousand USD | -64.646% |
| Nuwellis, Inc. | 221 Thousand USD | -103.386% |
| Biotricity, Inc. | 10.85 Million USD | 95.86% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 98.714% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | 30.822% |
| InspireMD, Inc. | 1.03 Million USD | 56.697% |
| PAVmed Inc. | 2.96 Million USD | 84.815% |
| BIOLASE, Inc. | 13.98 Million USD | 96.786% |
| Beyond Air, Inc. | 14.72 Million USD | 96.947% |
| FONAR Corporation | 37.92 Million USD | 98.815% |
| AxoGen, Inc. | 46.6 Million USD | 99.036% |
| Vivani Medical, Inc. | 19.31 Million USD | 97.673% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 98.992% |
| Inari Medical, Inc. | 30.35 Million USD | 98.519% |
| UFP Technologies, Inc. | 28 Million USD | 98.395% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -3.557% |
| Tenon Medical, Inc. | 428 Thousand USD | -5.019% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 55.141% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 79.115% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.979% |
| Sintx Technologies, Inc. | 3.68 Million USD | 87.809% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 98.792% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 23.557% |
| Sensus Healthcare, Inc. | 596 Thousand USD | 24.583% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.95% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.911% |
| ReWalk Robotics Ltd. | 607 Thousand USD | 25.95% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -386.006% |
| Hyperfine, Inc. | 64 Thousand USD | -602.317% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.762% |
| Biomerica, Inc. | 459 Thousand USD | 2.073% |
| Bone Biologics Corporation | - USD | -Infinity% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -136.586% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.406% |